Dr. Marc Claret receives a BBVA Foundation Grant for Researchers and Culture Creators
Dr. Marc Claret, head of the IDIBAPS group Neural Control of Metabolism, has received one of 63 BBVA Foundation Grants to Researchers and Culture...
Dr. Marc Claret, head of the IDIBAPS group Neural Control of Metabolism, has received one of 63 BBVA Foundation Grants to Researchers and Culture...
Dr. Eduard Vieta, head of the Psychiatry and Psychology department at Hospital Clínic and head of the IDIBAPS research group Biological bases of ps...
Doctors and researchers from Hospital Clínic and IDIBAPS were awarded in the second Vall d’Hebron Research Institute (VHIR) Health Innovation Cont...
The Spanish Agency for Medicines and Health Products (AEMPS) has approved a clinical trial in humans with an Antigen-Specific therapy with dendriti...
A study, published today in the journal Nature, marks a milestone in the understanding of chronic lymphocytic leukemia, the most common leukemia i...
A study published in the New England Journal of Medicine (NEJM) shows that abnormal lung development before 40 years of age predisposes to a diagn...
Researchers from IDIBAPS describe a molecular mechanism linking the development of type 2 diabetes with the malfunction of a cell organelle, the e...
Fingolimod, a drug used to treat multiple sclerosis, restores hippocampal synaptic plasticity and improves memory function. This is the main concl...
Throughout 2014 IDIBAPS promoted several activities to publicize the research develop in its laboratories through the urban natural drawing (urban...
On Monday July 6 took place the Welcoming Ceremony at the Hospital Clínic for the students of nursing Ph doctorate of the EANS (European Academy of...